Antibacterial activity of diaveridine, trimethoprim, and selected sulfonamides in prostatic fluid.
D000818:Animals; D004285:Dogs; D004357:Drug Synergism; D013293:Enterococcus faecalis / Q000187:drug effects; D004925:Escherichia / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects; D005493:Folic Acid Antagonists / Q000494:pharmacology*; D007709:Klebsiella / Q000187:drug effects; D008297:Male; D008826:Microbial Sensitivity Tests; D011467:Prostate / Q000378:metabolism*; D011472:Prostatitis / Q000188:drug therapy*; D011511:Proteus / Q000187:drug effects; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D011743:Pyrimidines / Q000494:pharmacology*; D013210:Staphylococcus / Q000187:drug effects; D013411:Sulfadiazine / Q000494:pharmacology; D013420:Sulfamethoxazole / Q000494:pharmacology; D013443:Sulfisomidine / Q000494:pharmacology; D013449:Sulfonamides / Q000494:pharmacology*
D005493:Folic Acid Antagonists; D011743:Pyrimidines; D013449:Sulfonamides; D013411:Sulfadiazine; D013420:Sulfamethoxazole; D013443:Sulfisomidine